ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0221

Identifying and Addressing Gaps in Systemic Lupus Erythematosus Care via Multimodal Continuing Medical Education

Katie Robinson1, Jillian Scavone1, William Cioffi1, Robert Esgro1 and Leonard Calabrese2, 1Vindico Medical Education, Thorofare, NJ, 2Cleveland Clinic, Cleveland, OH

Meeting: ACR Convergence 2022

Keywords: Education, Lupus nephritis, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 12, 2022

Title: Professional Education Poster

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: Given the recent advances in the management of patients systemic lupus erythematosus (SLE), rheumatology and primary care providers are challenged to administer the latest evidence-based care. To address this, a series of continuing medical education (CME) initiatives were implemented for distinct specialty audiences, and the impact of the education on provider knowledge and behaviors was measured.

Methods: Between November 2020 and May 2022, Vindico Medical Education provided 8 CME programs targeted to rheumatologists and primary care providers (PCPs) who see patients with SLE. Baseline knowledge and behaviors as well as educational impact were assessed via pre- and post-test, across 5 primary topics – incidence/risk, patient assessment, visceral organ involvement, corticosteroid safety, and optimizing treatment.

Results: Across activities, 9,274 healthcare providers participated in the education and 3,907 who see an average of 8 patients with SLE per month obtained CE credit. For both specialty cohorts (rheumatology and PCP), baseline knowledge was lowest regarding risks of steroids (22%) as well as risk associated with disease (37%), with specialists only slightly more knowledgeable at baseline. While rheumatologists had higher baseline knowledge than PCPs regarding patient assessment and treatment, specialists only scored 61% on these topics. Post-test scores across topics were 80% for specialists and 83% for PCPs, demonstrating robust educational impact. At baseline, 80% of rheumatologists and 67% of PCPs reported always or frequently identifying patients with SLE and organ involvement in a timely manner, though 34% and 73% lack confidence in doing so, respectively. Additionally, both cohorts note the management of patients with SLE and visceral organ involvement as their primary challenge in patient care. Post-education, rheumatology completers are more likely to administer evidence-based care, and, in 2022, 77% had reported using either of the new agents for LN. Moreover, three months following the education, 92% of providers reported implementing practice improvements, including improvements in patient assessment, treatment, and communication.

Conclusion: Recent advances in the management of patients with SLE have presented knowledge and practice gaps for providers, particularly regarding the long-term use of steroids and the management of patients with visceral organ involvement. This study highlights the efficacy of multimodal CE to address these gaps and encourage practice improvements. As data continues to evolve, rheumatology and primary care providers will require continued education to facilitate application of clinical advances to practice.


Disclosures: K. Robinson, None; J. Scavone, None; W. Cioffi, None; R. Esgro, None; L. Calabrese, AbbVie/Abbott, Bristol-Myers Squibb(BMS), Genentech, Janssen, UCB, Sanofi, Regeneron, Galvani, GlaxoSmithKlein(GSK), AstraZeneca, Chemocentryx.

To cite this abstract in AMA style:

Robinson K, Scavone J, Cioffi W, Esgro R, Calabrese L. Identifying and Addressing Gaps in Systemic Lupus Erythematosus Care via Multimodal Continuing Medical Education [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/identifying-and-addressing-gaps-in-systemic-lupus-erythematosus-care-via-multimodal-continuing-medical-education/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identifying-and-addressing-gaps-in-systemic-lupus-erythematosus-care-via-multimodal-continuing-medical-education/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology